Udaya Pratap Singh
11PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Mar 30, 2026
Design and Discovery of Substituted 1,3,4-Thiadiazole-1,3,5-Triazine Hybrids as Human Immunodeficiency Virus-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Anti-SARS-CoV-2 and Antibacterial Activities.Saumya Singh, Kumar Saurabh Srivastava, Mukesh Kumar Kumawat
|Aug 06, 2024
An in-depth analysis of COVID-19 treatment: Present situation and prospects.Md Ariful Islam, Kalyani Pathak, Riya Saikia
|Aug 18, 2023
Discovery of imeglimin-inspired novel 1,3,5-triazine derivatives as antidiabetic agents in streptozotocin-induced diabetes in Wistar rats via inhibition of DPP-4.Akanksha Gupta, Hans Raj Bhat, Udaya Pratap Singh
|Jun 12, 2023
Discovery of novel 1,3,5-triazine derivatives as an antidiabetic agent in Wistar rats via inhibition of DPP-4.Akanksha Gupta, Hans Raj Bhat, Udaya Pratap Singh
|Dec 21, 2022
Design and development of novel N-(4-aminobenzoyl)- l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitor: An in-silico and in-vitro study.Nayana Adhikari, Ayesha A K Choudhury, Anshul Shakya
|Mar 04, 2022
Implication of in silico studies in the search for novel inhibitors against SARS-CoV-2.Farak Ali, Shahnaz Alom, Anshul Shakya
Pageof 2
